Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.19540/j.cnki.cjcmm.20200330.501 http://scihub22266oqcxt.onion/10.19540/j.cnki.cjcmm.20200330.501 32726004!ä!32726004 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Zhongguo+Zhong+Yao+Za+Zhi 2020 ; 45 (13): 3001-3006 Nephropedia Template TP {{tp|p=32726004|t=2020. Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19) |pdf=|usr=}}{{32726004}} gab.com Text Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19) JO: Zhongguo Zhong Yao Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32726004 #FOAvip Coronavirus disease 2019(COVID-19) is a newly emerged and highly contagious respiratory disease. Traditional Chinese medicine(TCM) has both systematism theory knowledge and clinical practical value in the prevention and treatment of COVID-19. Therefore, it was particularly important to examine the effect of TCM in the prevention and treatment of COVID-19. The patents of TCM might reflect the latest progression of scientific research. We aimed to provide reference for the prevention and treatment of COVID-19 by extracting and analyzing the TCM patents from the Patent Information Sharing Platform of COVID-19. The antiviral TCM patents were screened and exported from the Patent Information Sharing Platform. VOSviewer 1.6.14 was used to visualize and analyze the network of TCM in these patents. There were total 292 TCM patents, including 52 patents for etiological treatment and 240 patents for symptomatic treatment. Thirty-two provinces and 1 076 inventors were involved, mainly from Beijing, Guangdong and Jiangsu. Overall, there were 356 TCMs, 71 single prescriptions, and 221 compound prescriptions. The patents for treatment of coronavirus mainly focused on the treatment of coronavirus, while the patents for symptomatic treatment mainly focuses on the improvement of respiratory symptoms, such as fever and cough. There were 14 highly frequently used TCMs, including Glycyrrhizae Radix et Rhizoma, Scutellariae Radix, Lonicerae Japonicae Flos, Forsythiae Fructus, Isatidis Radix, Astragali Radix, Menthae Haplocalycis Herba, Gypsum Fibrosum, Houttuyniae Herba, Isatidis Folium, Rhei Radix et Rhizoma, Gardeniae Fructus, Platycodonis Radix, Armeniacae Semen Amarum. The analyzed results of the TCM patents from the patent information sharing platform of COVID-19 were consistent with the Guideline of Diagnosis and Treatment of COVID-19(7th edition), and the combination of TCM in each cluster may also provide future directions for drug compatibility. Twit Text FOAVip Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19) ????Zhongguo Zhong Yao Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32726004 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32726004 #FOAvip English Wikipedia <ref>{{Cite pmid|32726004}}</ref> Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19) #MMPMID32726004 Yang KL; Gao Y; Yang FW; Liu M; Shi SZ; Chen YM; Zhang JH; Tian JH Zhongguo Zhong Yao Za Zhi 2020[Jul]; 45 (13): 3001-3006 PMID32726004show ga Coronavirus disease 2019(COVID-19) is a newly emerged and highly contagious respiratory disease. Traditional Chinese medicine(TCM) has both systematism theory knowledge and clinical practical value in the prevention and treatment of COVID-19. Therefore, it was particularly important to examine the effect of TCM in the prevention and treatment of COVID-19. The patents of TCM might reflect the latest progression of scientific research. We aimed to provide reference for the prevention and treatment of COVID-19 by extracting and analyzing the TCM patents from the Patent Information Sharing Platform of COVID-19. The antiviral TCM patents were screened and exported from the Patent Information Sharing Platform. VOSviewer 1.6.14 was used to visualize and analyze the network of TCM in these patents. There were total 292 TCM patents, including 52 patents for etiological treatment and 240 patents for symptomatic treatment. Thirty-two provinces and 1 076 inventors were involved, mainly from Beijing, Guangdong and Jiangsu. Overall, there were 356 TCMs, 71 single prescriptions, and 221 compound prescriptions. The patents for treatment of coronavirus mainly focused on the treatment of coronavirus, while the patents for symptomatic treatment mainly focuses on the improvement of respiratory symptoms, such as fever and cough. There were 14 highly frequently used TCMs, including Glycyrrhizae Radix et Rhizoma, Scutellariae Radix, Lonicerae Japonicae Flos, Forsythiae Fructus, Isatidis Radix, Astragali Radix, Menthae Haplocalycis Herba, Gypsum Fibrosum, Houttuyniae Herba, Isatidis Folium, Rhei Radix et Rhizoma, Gardeniae Fructus, Platycodonis Radix, Armeniacae Semen Amarum. The analyzed results of the TCM patents from the patent information sharing platform of COVID-19 were consistent with the Guideline of Diagnosis and Treatment of COVID-19(7th edition), and the combination of TCM in each cluster may also provide future directions for drug compatibility. |*Betacoronavirus[MESH] |*Coronavirus Infections/drug therapy[MESH] |*Drugs, Chinese Herbal[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/drug therapy[MESH] |Beijing[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Humans[MESH] |Information Dissemination[MESH] |Medicine, Chinese Traditional[MESH] Analysis of traditional Chinese medicine from patent information shar(epmc).pdf DeepDyve Pubget Overpricing